LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

Inngangur

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties eða psychedelic compounds. Production takes place under strict quality control.

Tæknilegar upplýsingar

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Hreinleiki: ≥98% (HPLC greining)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Rannsóknarumsóknir

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Gæðaeftirlit

Each batch is subjected to:

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Öryggisreglur

Meðhöndlun

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Geymsla

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Reglugerðarrammi

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Ekki hentugt til manneldis
• Export and distribution subject to regulations

Upplýsingar um pöntun

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Scientific References

• Nichols (2016) – Geðlyf sem lyf
• Brandt o.fl. (2020) – Lyfjafræði lýsergamíðs
• EMCDDA (2023) – Tæknileg skýrsla um ný geðvirk efni

Mikilvæg athugasemd

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

1cP-LSD 150 MCG listabletti O-DSMT 50 mg kúlur 1V-LSD 150 MCG þynnur 6-CL-ADBA 2-CMC 250 mg kúlur